Anti-Mouse IFN Beta Antibody, Clone RMMB-1 (MAb)
Specifications
| Formulation | Supplied frozen in phosphate-buffered saline (PBS) containing 0.1% Bovine Serum Albumin (BSA) |
| Antigen | Mouse interferon beta |
| Isotype | IgG2ak |
| Host Species | Rat |
| Purity | > 95% by SDS-PAGE stained by Coomassie Blue Endotoxin level < 1 EU/μg |
| Bioactivity | Measured by neutralization of interferon in cytopathic effect inhibition assay |
| Specificity | Weakly neutralizes mouse IFN-beta, but not recommended for neutralization assays (for this application products 32400-1 or 32401-1 are recommended) ; binds to mouse IFN-beta |
| Storage | For retention of full activity store at -20°C or below and avoid repeated freeze/thaw cycles |
| Antigen Synonyms | Mouse IFN Beta, Mouse Beta Interferon, Mouse IFNB, Mouse Type I IFN beta, Mouse Fibroblast IFN, Mouse Fibroblast Interferon, Mouse Beta IFN, Mouse Type I Interferon Beta |
| Clone | RMMB-1 |
Tech Info / Data
Tested Applications:
- Direct Binding ELISA
Note: PBL has not tested the use of this product in western blot, flow cytometry, immunoprecipitation or immunohistochemistry.
Documentation
Direct Binding ELISA
Representative binding curve of antibody to recombinant Mouse IFN Beta (circle) and to 1% BSA/PBS (square) in a Direct Binding ELISA.
Related Products
| Catalog No. | Description | Pack Size | Price | Quantity |
|---|---|---|---|---|
| 12405-1 |
Mouse Interferon Beta, mammalian new |
1 x 105 units |
$260.00 |
|
| 32400-1 |
Anti-Mouse Interferon Beta, Rabbit Serum (PAb) |
2 x 104 units |
$355.00 |
|
| 32401-1 |
Anti-Mouse Interferon Beta, Rabbit IgG, Protein A purified (PAb) |
2 x 104 units |
$415.00 |
|
| 12400-1 |
Mouse Interferon Beta |
1 x 105 units |
$495.00 |
Find your product of interest by searching for category, species, molecule and/or application.
Visit our blog to read about recent developments in the fields of interferon, cytokine and biomarker research!
Sign up for our mailing list to be kept up-to-date on the latest promotions, company and product news.
